Market

Lupin receives EIR from US FDA for its injectable facility in Nagpur

Read more

Glenmark gets second tentative ANDA approval for Saxagliptin Tablets, 2.5 mg and 5 mg

Read more

Moderna’s non-vaccine mRNA therapeutic can generate $278 million in 2028 if approved: GlobalData

Read more

GUERISON forays into India’s ophthalmology market

Read more

Herbalife Nutrition India forays into eye health segment with ocular defense

Read more

Asahi Kasei completes construction of second plant for Ceolus microcrystalline cellulose

Read more

Rising costs forced patients to postpone or stop treatments in 2022: GlobalData

Read more

NATCO announces ANDA filing for generic olaparib tablets in US

Read more

Sun Pharma recalls 34000 bottles of Diltiazem Hydrochloride extended-release capsules from US

Read more

AI facilitates low-cost drug repurposing: GlobalData

Read more